Cancer Center Amsterdam
-
AKT supports the metabolic fitness of multiple myeloma cells by restricting FOXO activity
Bloedjes, T. A., de Wilde, G., Khan, G. H., Ashby, T. C., Shaughnessy, J. D., Zhan, F., Houtkooper, R. H., Bende, R. J., van Noesel, C. J. M., Spaargaren, M. & Guikema, J. E. J., 9 May 2023, In: Blood advances. 7, 9, p. 1697-1712 16 p.Research output: Contribution to journal › Article › Academic › peer-review
-
SMG1, a nonsense-mediated mRNA decay (NMD) regulator, as a candidate therapeutic target in multiple myeloma
Leeksma, A. C., Derks, I. A. M., Garrick, B., Jongejan, A., Colombo, M., Bloedjes, T., Trowe, T., Leisten, J. C., Howarth, M., Malek, M., Mortensen, D. S., Blease, K., Groza, M. C., Narla, R. K., Loos, R., Kersten, M-J., Moerland, P. D., Guikema, J. E. J., Kater, A. P., Eldering, E., & 1 others, 18 Nov 2022, (E-pub ahead of print) In: Molecular Oncology.Research output: Contribution to journal › Article › Academic › peer-review
-
Metabolic effects of recurrent genetic aberrations in multiple myeloma
Bloedjes, T. A., de Wilde, G. & Guikema, J. E. J., 1 Feb 2021, In: Cancers. 13, 3, p. 1-36 36 p., 396.Research output: Contribution to journal › Review article › Academic › peer-review
- All publications